Bolt Biotherapeutics, Inc. (BOLT) insider trading.
In Q3 2026, insiders at Bolt Biotherapeutics, Inc. reported 11 non-derivative transactions on 3 Forms 3, 4 and 5: 2 open-market purchases worth $4K and 9 sales worth $128K.
- Transactions
- 11
- Purchases (P)
- 2
- Sales (S)
- 9
- Net shares, P minus S
- -37,438
- Insiders
- 3
- Last filed
- 2026-09-21
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Quinn William P. | Director, Officer · President, CEO and CFO | 4 | 1 | 3 |
| Nemec Sarah | Officer · Senior VP, Finance and PAO | 4 | 1 | 3 |
| Yonehiro Grant | Officer · Chief Operating Officer | 3 | 0 | 3 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Quinn William P. | S (D) | 9,132 | $3.24 | 25,384 | Form 4 |
| 2026-09-18 | Nemec Sarah | S (D) | 4,077 | $3.24 | 17,082 | Form 4 |
| 2026-09-18 | Yonehiro Grant | S (D) | 6,850 | $3.24 | 17,269 | Form 4 |
| 2026-09-17 | Quinn William P. | S (D) | 6,545 | $3.32 | 34,516 | Form 4 |
| 2026-09-17 | Nemec Sarah | S (D) | 2,922 | $3.32 | 21,159 | Form 4 |
| 2026-09-17 | Yonehiro Grant | S (D) | 4,909 | $3.32 | 24,119 | Form 4 |
| 2026-09-16 | Quinn William P. | S (D) | 1,889 | $3.77 | 41,061 | Form 4 |
| 2026-09-16 | Nemec Sarah | S (D) | 843 | $3.77 | 24,081 | Form 4 |
| 2026-09-16 | Yonehiro Grant | S (D) | 1,417 | $3.77 | 29,028 | Form 4 |
| 2026-06-05 | Quinn William P. | P (A) | 637 | $3.88 | 2,950 | Form 4 |
| 2026-06-05 | Nemec Sarah | P (A) | 509 | $3.88 | 1,924 | Form 4 |
Transaction codes in this quarter
Get BOLT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1641281&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BOLT company page · Bolt Biotherapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Bolt Biotherapeutics, Inc. (BOLT)?
In Q3 2026, insiders at Bolt Biotherapeutics, Inc. reported 11 non-derivative transactions on 3 Forms 3, 4 and 5: 2 open-market purchases worth $4K and 9 sales worth $128K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Bolt Biotherapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/bolt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.